| 111. |
Garg S, Thongcharoen P, Prapasiri P, Chitwarakorn A, Sathirapanya P, Fernandez S, Rungrojcharoenkit K, Chonwattana W, Mock PA, Sukwicha W, Katz JM, Widdowson MA, Curlin ME, Gibbons RV, Holtz T, Dawood FS, Olsen SJ.
.
Randomized Controlled Trial to Compare Immunogenicity of Standard Dose Intramuscular versus Intradermal Trivalent Inactivated Influenza Vaccine in HIV-infected Men who have Sex with Men in Bangkok, Thailand.
.
Clin Infect Dis.
2015.
62
(3):
383-391.
Department : Microbiology
Journal Name : Clin Infect Dis
/ IF = 8.886
Source : Pubmed
|
| 112. |
Gianni, L; Pienkowski, T; Im, YH; Tseng, LM; Liu, MC; Lluch, A; Staroslawska, E; de la Haba-Rodriguez, J; Im, SA; Pedrini, JL; Poirier, B; Morandi, P; Semiglazov, V; Srimuninnimit, V; Bianchi, GV; McNally, V; Douthwaite, H; Ross, G; Valagussa, P.
Five-year analysis of the phase II NeoSphere trial evaluating four cycles of neoadjuvant docetaxel (D) and/or trastuzumab (T) and/or pertuzumab (P).
JOURNAL OF CLINICAL ONCOLOGY.
2015.
33
(15):
Department : Department of Medicine
Journal Name : JOURNAL OF CLINICAL ONCOLOGY
/ IF = 18.428
Source : ISI
|
| 113. |
Goh CL, Abad-Casintahan F, Aw DC, Baba R, Chan LC, Hung NT, Kulthanan K, Leong HN, Medina-Oblepias MS, Noppakun N, Sitohang IB, Sugito TL, Wong SN.
South-East Asia study alliance guidelines on the management of acne vulgaris in South-East Asian patients.
J Dermatol.
2015.
Department : Department of Dermatology
Journal Name : J Dermatol
/ IF = 2.252
Source : Pubmed
|
| 114. |
Goodson WH 3rd, Lowe L, Carpenter DO, Gilbertson M, Manaf Ali A, Lopez de Cerain Salsamendi A, Lasfar A, Carnero A, Azqueta A, Amedei A, Charles AK, Collins AR, Ward A, Salzberg AC, Colacci A, Olsen AK, Berg A, Barclay BJ, Zhou BP, Blanco-Aparicio C, Baglole CJ, Dong C, et al.
Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead.
Carcinogenesis.
2015.
36
(Suppl 1):
S254-96-S296.
Department : Stem cell
Journal Name : Carcinogenesis
/ IF = 5.334
Source : Pubmed
|
| 115. |
Grainger J.D., Locatelli F., Chotsampancharoen T., Donyush E., Pongtanakul B., Komvilaisak P., Sosothikul D., Drelichman G., Sirachainan N., Holzhauer S., Lebedev V., Lemons R., Pospisilova D., Ramenghi U., Bussel J.B., Bakshi K.K., Iyengar M., Chan G.W., Chagin K.D., Theodore D., Marcello L.M., Bailey C.K.
Eltrombopag for children with chronic immune thrombocytopenia (PETIT2): A randomised, multicentre, placebo-controlled trial.
The Lancet.
2015.
Department : Department of Pediatrics
Journal Name : The Lancet
/ IF = 45.217
Source : Scopus
|
|
